Shu‐Chih Su
About
In The Last Decade
Shu‐Chih Su
14 papers receiving 306 citations
Peers
Comparison fields: 5 of 56
- Epidemiology 206
- Parasitology 61
- Oncology 54
- Dermatology 49
- Virology 43
Countries citing papers authored by Shu‐Chih Su
This map shows the geographic impact of Shu‐Chih Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Chih Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Chih Su more than expected).
Fields of papers citing papers by Shu‐Chih Su
This network shows the impact of papers produced by Shu‐Chih Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Chih Su. The network helps show where Shu‐Chih Su may publish in the future.
Co-authorship network of co-authors of Shu‐Chih Su
This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Chih Su. A scholar is included among the top collaborators of Shu‐Chih Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Chih Su. Shu‐Chih Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 9 | |
| 3 | 13 | |
| 4 | 20 | |
| 5 | Keynote-966 trial in progress: pembrolizumab added to gemcitabine and cisplatin for advanced biliary tract cancer | 0 |
| 6 | 11 | |
| 7 | 5 | |
| 8 | 4 | |
| 9 | 18 | |
| 10 | 54 | |
| 11 | 26 | |
| 12 | 29 | |
| 13 | 23 | |
| 14 | 50 | |
| 15 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.